NEW YORK (GenomeWeb) –Vanderbilt University Medical Center yesterday announced it has received a five-year $12.8 million grant from the National Institutes of Health for a new phamacogenomics research center.

Vanderbilit received the so-called "P50" grant from the National Institute of General Medical Sciences' Pharmacogenomics Research Network (PGRN) to establish a specialized research center for pharmacogenomics and personalized medicine.

Vanderbilt faculty members Dan Roden, Josh Denny, and Elizabeth Phillips are the co-principal investigators for the grant.